RYOIX vs. RYAIX
Compare and contrast key facts about Rydex Biotechnology Fund (RYOIX) and Rydex Inverse NASDAQ-100 Strategy Fund (RYAIX).
RYOIX is managed by Rydex Funds. It was launched on Mar 31, 1998. RYAIX is managed by Rydex Funds. It was launched on Sep 2, 1998.
Performance
RYOIX vs. RYAIX - Performance Comparison
Loading graphics...
RYOIX vs. RYAIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | -2.83% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
RYAIX Rydex Inverse NASDAQ-100 Strategy Fund | 10.70% | -15.63% | -15.64% | -31.71% | 35.92% | -24.88% | -40.98% | -27.65% | -2.63% | -24.47% |
Returns By Period
In the year-to-date period, RYOIX achieves a -2.83% return, which is significantly lower than RYAIX's 10.70% return. Over the past 10 years, RYOIX has outperformed RYAIX with an annualized return of 8.46%, while RYAIX has yielded a comparatively lower -16.89% annualized return.
RYOIX
- 1D
- 1.00%
- 1M
- -6.92%
- YTD
- -2.83%
- 6M
- 11.88%
- 1Y
- 28.65%
- 3Y*
- 10.88%
- 5Y*
- 3.74%
- 10Y*
- 8.46%
RYAIX
- 1D
- 0.78%
- 1M
- 8.79%
- YTD
- 10.70%
- 6M
- 9.08%
- 1Y
- -14.68%
- 3Y*
- -13.58%
- 5Y*
- -10.67%
- 10Y*
- -16.89%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYOIX vs. RYAIX - Expense Ratio Comparison
RYOIX has a 1.36% expense ratio, which is lower than RYAIX's 1.55% expense ratio.
Return for Risk
RYOIX vs. RYAIX — Risk / Return Rank
RYOIX
RYAIX
RYOIX vs. RYAIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Biotechnology Fund (RYOIX) and Rydex Inverse NASDAQ-100 Strategy Fund (RYAIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYOIX | RYAIX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | -0.65 | +1.79 |
Sortino ratioReturn per unit of downside risk | 1.64 | -0.79 | +2.43 |
Omega ratioGain probability vs. loss probability | 1.21 | 0.89 | +0.32 |
Calmar ratioReturn relative to maximum drawdown | 1.71 | -0.36 | +2.07 |
Martin ratioReturn relative to average drawdown | 6.79 | -0.45 | +7.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYOIX | RYAIX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | -0.65 | +1.79 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | -0.47 | +0.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | -0.75 | +1.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | -0.16 | +0.51 |
Correlation
The correlation between RYOIX and RYAIX is -0.67. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
RYOIX vs. RYAIX - Dividend Comparison
RYOIX's dividend yield for the trailing twelve months is around 12.93%, more than RYAIX's 2.01% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 12.93% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
RYAIX Rydex Inverse NASDAQ-100 Strategy Fund | 2.01% | 2.23% | 5.67% | 4.81% | 0.00% | 0.00% | 0.09% | 0.72% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RYOIX vs. RYAIX - Drawdown Comparison
The maximum RYOIX drawdown since its inception was -74.43%, smaller than the maximum RYAIX drawdown of -98.75%. Use the drawdown chart below to compare losses from any high point for RYOIX and RYAIX.
Loading graphics...
Drawdown Indicators
| RYOIX | RYAIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.43% | -98.75% | +24.32% |
Max Drawdown (1Y)Largest decline over 1 year | -12.10% | -33.93% | +21.83% |
Max Drawdown (5Y)Largest decline over 5 years | -33.66% | -54.73% | +21.07% |
Max Drawdown (10Y)Largest decline over 10 years | -33.66% | -87.23% | +53.57% |
Current DrawdownCurrent decline from peak | -7.52% | -98.56% | +91.04% |
Average DrawdownAverage peak-to-trough decline | -27.81% | -73.13% | +45.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.65% | 27.19% | -23.54% |
Volatility
RYOIX vs. RYAIX - Volatility Comparison
Rydex Biotechnology Fund (RYOIX) has a higher volatility of 6.76% compared to Rydex Inverse NASDAQ-100 Strategy Fund (RYAIX) at 5.34%. This indicates that RYOIX's price experiences larger fluctuations and is considered to be riskier than RYAIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYOIX | RYAIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.76% | 5.34% | +1.42% |
Volatility (6M)Calculated over the trailing 6-month period | 13.23% | 12.33% | +0.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.95% | 22.52% | +0.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.08% | 22.82% | -1.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.33% | 22.58% | +0.75% |